US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Telix Pharmaceuticals Ltd. (Uplisting)

11.12

+0.34003.15%

Post-market: 11.120.00000.00%19:30 EDT

Volume:817.44K

Turnover:9.07M

Market Cap:3.77B

PE:116.58

High:11.14

Open:11.01

Low:11.00

Close:10.78

52wk High:13.11

52wk Low:6.28

Shares:339.00M

Float Shares:272.00M

Volume Ratio:3.11

T/O Rate:0.30%

Dividend:- -

Dividend Rate:- -

EPS(TTM):0.0954

EPS(LYR):-0.0211

ROE:7.36%

ROA:2.71%

PB:7.73

PE(LYR):-527.01

Loading ...

Overview Company News Filings

Telix Pharmaceuticals (ASX:TLX) Could Be 35% Below Fair Value On Pixclara Launch

Simply Wall St.

Telix Doses First US Patients With FDA-Approved Brain Cancer Imaging Drug

MT Newswires Live

How Investors Are Reacting To Telix Pharmaceuticals (ASX:TLX) Fast Track Nod

Simply Wall St.

Canaccord Genuity Keeps Their Buy Rating on Telix Pharmaceuticals (TLPPF)

Telix Pharmaceuticals Reports Lapse of Conditional Equity Securities

Telix Issues 15,000 New Shares From Conversion of Unquoted Securities

Telix Adds 436,366 New Shares to ASX Listing

Liontown And 2 Other Australian Growth Stocks To Watch

Simply Wall St.

3 Australian Founder Led Growth Stocks To Own In October 2026

Simply Wall St.

Telix Wins FDA Fast Track for Pre-Biopsy Prostate Cancer Imaging Program

Ord Minnett Remains a Buy on Telix Pharmaceuticals (TLPPF)

Telix Pharmaceuticals Price Target Maintained with a $20.00/Share by HC Wainwright & Co.

Analysts Offer Insights on NA Companies: Ford Motor (F) and Telix Pharmaceuticals Limited Unsponsored ADR (TLX)

Telix Director David Gill Boosts Nasdaq ADS Stake

Telix Pharmaceuticals Price Target Maintained with a $22.00/Share by Wedbush

Citi Remains a Buy on Telix Pharmaceuticals (TLPPF)

Analysts’ Top NA Picks: MillerKnoll (MLKN), Telix Pharmaceuticals Limited Unsponsored ADR (TLX)

RBC upgrades Telix to Outperform on ITM deal benefits

UBS Sticks to Their Buy Rating for Telix Pharmaceuticals (TLPPF)

Telix Pharmaceuticals Receives ASX Waivers on Share Issuance Timing for Acquisition Consideration

MT Newswires Live

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/TLX/news"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TLX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX\",,,,,undefined,":{"symbol":"TLX","market":"US","secType":"STK","nameCN":"Telix Pharmaceuticals Ltd. (Uplisting)","latestPrice":11.12,"timestamp":1791403200000,"preClose":10.78,"halted":0,"volume":817437,"hourTrading":{"tag":"盘后","latestPrice":11.12,"preClose":11.12,"latestTime":"19:30 EDT","volume":2122,"amount":23595.9975,"timestamp":1791415802396,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":0.03153988868274581,"floatShares":272000000,"shares":339000000,"eps":0.095386,"marketStatus":"Not Yet Opened","change":0.34,"latestTime":"10-07 16:00:00 EDT","open":11.01,"high":11.14,"low":11,"amount":9070627.545288,"amplitude":0.012987,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.095386,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1791446400000},"marketStatusCode":0,"adr":0,"adrRate":1,"listingDate":1718337600000,"exchange":"NASDAQ","adjPreClose":10.78,"preHourTrading":{"tag":"盘前","latestPrice":11.01,"preClose":10.78,"latestTime":"09:26 EDT","volume":356,"amount":3953.37822,"timestamp":1791379609221,"change":0.23,"changeRate":0.021336,"amplitude":0.07782},"postHourTrading":{"tag":"盘后","latestPrice":11.12,"preClose":11.12,"latestTime":"19:30 EDT","volume":2122,"amount":23595.9975,"timestamp":1791415802396,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":3.105643},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TLX\",,,,,undefined,":{"symbol":"TLX","floatShares":272000000,"roa":"2.71%","roe":"7.36%","lyrEps":-0.0211,"volumeRatio":3.105643,"shares":339000000,"dividePrice":0,"high":11.14,"amplitude":0.012987,"preClose":10.78,"low":11,"week52Low":6.28,"pbRate":"7.73","psRate":"4.23","week52High":13.1098,"institutionHeld":0,"latestPrice":11.12,"eps":0.095386,"divideRate":0,"volume":817437,"delay":0,"ttmEps":0.095386,"open":11.01,"prevYearClose":7.49,"prevWeekClose":10.55,"prevMonthClose":10.97,"prevQuarterClose":10.97,"fiveDayClose":10.97,"twentyDayClose":12.34,"sixtyDayClose":11.02},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TLX\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-02-19","symbol":"TLX","fiscalQuarterEnding":"2025/12","expectedEps":0.04,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1771477200000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-08-20","symbol":"TLX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Post-Mkt","type":"earning","dateTimestamp":1755662400000,"reportTimeType":"post","actualEps":null},{"market":"US","date":"2025-02-20","symbol":"TLX","fiscalQuarterEnding":null,"expectedEps":null,"name":null,"time":"Pre-MKt","type":"earning","dateTimestamp":1740027600000,"reportTimeType":"pre","actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TLX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TLX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.6,"buy":0.4,"hold":0,"sell":0,"strongSell":0,"meanLabel":"STRONG BUY","meanPercent":0.6,"analysts":5,"updateTime":1758254400000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TLX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TLX","date":"2026-10-06","current":116.578953,"percent":0.264831,"low":-584.49693,"twenty":-430.395937,"median":169.706271,"eighty":241.476195,"high":383.853933,"avg":28.153881,"sd":305.104965,"marketCap":3655711771.28},"quantilePoints":[{"date":"2024-11-15","current":155.824924,"twenty":155.852142,"median":155.89297,"eighty":156.178762,"marketCap":4970652360.72},{"date":"2024-11-22","current":153.647458,"twenty":154.191824,"median":155.858947,"eighty":156.314854,"marketCap":4920980791.17},{"date":"2024-11-29","current":168.345354,"twenty":154.8995,"median":156.063085,"eighty":158.49232,"marketCap":5381208976.41},{"date":"2024-12-06","current":169.502133,"twenty":155.171684,"median":156.641474,"eighty":168.045953,"marketCap":5368295184.8},{"date":"2024-12-13","current":166.916392,"twenty":155.838533,"median":162.3233,"eighty":168.045953,"marketCap":5240175366.69},{"date":"2024-12-20","current":168.345354,"twenty":155.961016,"median":166.508117,"eighty":168.916939,"marketCap":5183140063.85},{"date":"2024-12-27","current":169.774316,"twenty":156.233199,"median":167.052484,"eighty":169.706271,"marketCap":5196235069.7},{"date":"2025-01-03","current":162.241165,"twenty":156.342072,"median":167.052484,"eighty":169.542961,"marketCap":4949346723.31},{"date":"2025-01-10","current":163.261978,"twenty":156.5326,"median":167.392713,"eighty":169.228803,"marketCap":4970930045.19},{"date":"2025-01-17","current":180.956065,"twenty":158.029608,"median":167.50507,"eighty":169.864326,"marketCap":5535715919.89},{"date":"2025-01-24","current":187.353158,"twenty":159.608271,"median":167.889662,"eighty":170.577257,"marketCap":5785750657.37},{"date":"2025-01-31","current":199.670965,"twenty":161.249345,"median":168.229933,"eighty":175.407845,"marketCap":6122321793.53},{"date":"2025-02-07","current":198.349538,"twenty":162.241165,"median":168.549491,"eighty":182.861582,"marketCap":6131109878.71},{"date":"2025-02-14","current":185.473256,"twenty":162.64949,"median":169.046583,"eighty":187.353158,"marketCap":5747906307.1},{"date":"2025-02-21","current":203.261161,"twenty":163.302811,"median":169.706271,"eighty":187.353158,"marketCap":6486347833.54},{"date":"2025-02-28","current":187.883767,"twenty":163.584606,"median":170.12499,"eighty":192.087093,"marketCap":5864055113.17},{"date":"2025-03-07","current":182.602424,"twenty":164.112905,"median":170.795004,"eighty":190.960114,"marketCap":5800401146.04},{"date":"2025-03-14","current":179.829719,"twenty":164.766144,"median":174.911776,"eighty":189.692293,"marketCap":5647282174.13},{"date":"2025-03-21","current":184.714961,"twenty":166.589772,"median":175.670662,"eighty":188.147066,"marketCap":5803981960.09},{"date":"2025-03-28","current":187.327482,"twenty":166.94361,"median":178.971501,"eighty":190.960114,"marketCap":5900183330.18},{"date":"2025-04-04","current":159.860903,"twenty":166.94361,"median":178.262158,"eighty":189.692293,"marketCap":5073492527.81},{"date":"2025-04-11","current":177.179731,"twenty":166.589772,"median":177.679515,"eighty":188.147066,"marketCap":5496976372.28},{"date":"2025-04-17","current":173.797147,"twenty":166.916392,"median":177.619467,"eighty":187.883767,"marketCap":5535140863.85},{"date":"2025-04-25","current":193.309359,"twenty":167.052484,"median":178.059203,"eighty":190.062144,"marketCap":6172717887.8},{"date":"2025-05-02","current":198.453445,"twenty":167.392713,"median":178.295984,"eighty":190.062144,"marketCap":6327668326.52},{"date":"2025-05-09","current":181.396737,"twenty":167.481337,"median":179.235568,"eighty":190.062144,"marketCap":5809793224.05},{"date":"2025-05-16","current":176.029393,"twenty":167.481337,"median":178.295984,"eighty":189.78972,"marketCap":5619140101.04},{"date":"2025-05-23","current":172.647682,"twenty":167.528804,"median":178.059203,"eighty":189.451294,"marketCap":5528513460.13},{"date":"2025-05-30","current":176.779306,"twenty":167.780801,"median":177.456621,"eighty":188.460572,"marketCap":5687082652.57},{"date":"2025-06-06","current":173.121803,"twenty":167.88049,"median":177.318176,"eighty":187.949592,"marketCap":5638091901.1},{"date":"2025-06-13","current":167.838743,"twenty":167.88049,"median":176.508379,"eighty":187.45928,"marketCap":5463186103.94},{"date":"2025-06-20","current":168.923551,"twenty":167.889662,"median":176.029393,"eighty":187.353158,"marketCap":5442074695.06},{"date":"2025-06-27","current":165.669807,"twenty":167.592888,"median":175.625224,"eighty":187.337752,"marketCap":5412704421.76},{"date":"2025-07-03","current":162.348276,"twenty":167.428163,"median":175.082406,"eighty":187.024133,"marketCap":5325445922.59},{"date":"2025-07-11","current":163.297285,"twenty":166.671427,"median":174.480785,"eighty":186.439488,"marketCap":5350247552.51},{"date":"2025-07-18","current":171.228286,"twenty":165.90028,"median":173.909122,"eighty":186.045921,"marketCap":5541358073.91},{"date":"2025-07-25","current":144.045965,"twenty":165.670181,"median":173.731386,"eighty":185.637634,"marketCap":4750367012.62},{"date":"2025-08-01","current":136.589468,"twenty":164.955304,"median":173.25664,"eighty":185.381192,"marketCap":4384547406.6},{"date":"2025-08-08","current":119.575098,"twenty":163.364827,"median":173.121803,"eighty":185.031841,"marketCap":3879545892.37},{"date":"2025-08-15","current":118.626089,"twenty":162.985468,"median":172.816584,"eighty":184.520886,"marketCap":3844757658.1},{"date":"2025-08-22","current":367.342977,"twenty":162.565192,"median":172.783145,"eighty":185.031841,"marketCap":3983594342.69},{"date":"2025-08-29","current":297.28853,"twenty":162.917681,"median":173.086118,"eighty":186.439488,"marketCap":3223899680.91},{"date":"2025-09-05","current":280.194275,"twenty":162.97191,"median":173.155042,"eighty":187.353158,"marketCap":3038523660.62},{"date":"2025-09-12","current":284.24913,"twenty":163.053254,"median":173.392729,"eighty":189.722035,"marketCap":3082495919.22},{"date":"2025-09-19","current":299.993591,"twenty":163.181765,"median":173.840405,"eighty":192.411646,"marketCap":3253234303.96},{"date":"2025-09-26","current":303.368871,"twenty":163.269039,"median":174.34097,"eighty":195.332201,"marketCap":3289837005.56},{"date":"2025-10-03","current":316.222238,"twenty":163.331056,"median":174.844246,"eighty":197.182743,"marketCap":3429223360.77},{"date":"2025-10-10","current":308.943311,"twenty":163.584606,"median":175.579785,"eighty":198.432664,"marketCap":3350288154.24},{"date":"2025-10-17","current":337.724829,"twenty":164.112905,"median":175.99796,"eighty":200.117317,"marketCap":3662404902.51},{"date":"2025-10-24","current":335.676999,"twenty":164.422238,"median":176.508379,"eighty":204.373856,"marketCap":3640197520.67},{"date":"2025-10-31","current":328.898919,"twenty":164.871944,"median":177.318176,"eighty":280.077091,"marketCap":3566693671.28},{"date":"2025-11-07","current":302.845362,"twenty":165.230483,"median":178.059203,"eighty":285.744085,"marketCap":3284159889.46},{"date":"2025-11-14","current":289.051675,"twenty":165.371547,"median":178.295984,"eighty":290.299055,"marketCap":3134576370.19},{"date":"2025-11-21","current":278.19044,"twenty":165.561349,"median":179.014446,"eighty":289.541689,"marketCap":3016793389.39},{"date":"2025-11-28","current":310.533522,"twenty":165.669807,"median":179.412236,"eighty":291.060611,"marketCap":3367532955.32},{"date":"2025-12-05","current":306.208941,"twenty":165.670741,"median":180.00406,"eighty":294.691227,"marketCap":3320635708.33},{"date":"2025-12-12","current":286.055209,"twenty":165.873166,"median":180.584513,"eighty":295.905706,"marketCap":3102081667.78},{"date":"2025-12-19","current":244.707348,"twenty":165.940952,"median":181.091444,"eighty":294.691227,"marketCap":2653691145.03},{"date":"2025-12-26","current":248.848958,"twenty":166.394684,"median":181.60348,"eighty":294.390689,"marketCap":2698604201.29},{"date":"2026-01-02","current":236.757004,"twenty":166.574536,"median":182.507221,"eighty":293.840477,"marketCap":2567474872.89},{"date":"2026-01-09","current":234.880062,"twenty":166.797362,"median":182.734458,"eighty":292.111558,"marketCap":2547120662.92},{"date":"2026-01-16","current":240.619616,"twenty":166.998047,"median":183.212494,"eighty":291.104403,"marketCap":2609362374.53},{"date":"2026-01-23","current":233.793317,"twenty":167.188576,"median":183.578507,"eighty":290.823686,"marketCap":2535335622.99},{"date":"2026-01-30","current":230.611959,"twenty":167.428163,"median":183.988776,"eighty":290.419247,"marketCap":2500835870.83},{"date":"2026-02-06","current":214.320895,"twenty":167.500324,"median":184.979028,"eighty":290.056234,"marketCap":2324169939.4},{"date":"2026-02-13","current":194.105832,"twenty":167.571527,"median":185.74722,"eighty":289.461299,"marketCap":2104950801.53},{"date":"2026-02-20","current":-349.931165,"twenty":167.550165,"median":186.245055,"eighty":289.186438,"marketCap":2493259551.93},{"date":"2026-02-27","current":-337.576812,"twenty":166.94361,"median":185.358176,"eighty":288.884688,"marketCap":2405234781.68},{"date":"2026-03-06","current":-357.014534,"twenty":165.886723,"median":184.229774,"eighty":287.796958,"marketCap":2543728559.75},{"date":"2026-03-13","current":-380.87359,"twenty":165.371547,"median":183.661424,"eighty":286.105301,"marketCap":2713724328.68},{"date":"2026-03-20","current":-427.441295,"twenty":164.112905,"median":183.427298,"eighty":285.888656,"marketCap":3045519229.47},{"date":"2026-03-27","current":-448.04178,"twenty":163.181765,"median":182.800475,"eighty":285.212188,"marketCap":3192297684.03},{"date":"2026-04-02","current":-425.435204,"twenty":162.890567,"median":182.629922,"eighty":285.17117,"marketCap":3031225831.43},{"date":"2026-04-10","current":-492.382264,"twenty":161.467054,"median":181.810223,"eighty":284.24913,"marketCap":3508223631.57},{"date":"2026-04-17","current":-499.465833,"twenty":158.955031,"median":181.091444,"eighty":284.07528,"marketCap":3558694058.36},{"date":"2026-04-24","current":-507.89561,"twenty":156.233199,"median":180.584513,"eighty":282.031139,"marketCap":3618756217.23},{"date":"2026-05-01","current":-532.518745,"twenty":154.872282,"median":180.00406,"eighty":281.147736,"marketCap":3794196059.21},{"date":"2026-05-08","current":-508.824558,"twenty":144.045965,"median":179.412236,"eighty":280.966174,"marketCap":3625374971.37},{"date":"2026-05-15","current":-506.065728,"twenty":140.182144,"median":178.86094,"eighty":280.209239,"marketCap":3605718311.9},{"date":"2026-05-22","current":-452.537308,"twenty":125.947014,"median":178.262158,"eighty":280.194275,"marketCap":3224328322.29},{"date":"2026-05-29","current":-444.681415,"twenty":120.122064,"median":178.059203,"eighty":279.725537,"marketCap":3168355079.47},{"date":"2026-06-05","current":-452.683664,"twenty":115.968865,"median":177.318176,"eighty":279.589795,"marketCap":3225371110.32},{"date":"2026-06-12","current":-453.131496,"twenty":29.784924,"median":176.508379,"eighty":278.469383,"marketCap":3228561906.13},{"date":"2026-06-18","current":-479.232706,"twenty":-319.885885,"median":176.029393,"eighty":275.361846,"marketCap":3414533028.17},{"date":"2026-06-26","current":-505.22407,"twenty":-336.088027,"median":175.625224,"eighty":265.637187,"marketCap":3599721496.58},{"date":"2026-07-02","current":-567.292731,"twenty":-347.690038,"median":175.082406,"eighty":259.576863,"marketCap":4041960704.33},{"date":"2026-07-10","current":-538.02731,"twenty":-371.335373,"median":174.480785,"eighty":256.751103,"marketCap":3833444584.84},{"date":"2026-07-17","current":-497.824928,"twenty":-406.861587,"median":173.909122,"eighty":252.484997,"marketCap":3547002606.6},{"date":"2026-07-24","current":-487.362208,"twenty":-419.925535,"median":173.731386,"eighty":249.449835,"marketCap":3472455733.71},{"date":"2026-07-31","current":-475.018244,"twenty":-425.317007,"median":173.324997,"eighty":249.116107,"marketCap":3384504988.78},{"date":"2026-08-07","current":-543.110083,"twenty":-431.380818,"median":173.121803,"eighty":248.587668,"marketCap":3869659340.88},{"date":"2026-08-14","current":-563.285348,"twenty":-444.416873,"median":172.850024,"eighty":247.242146,"marketCap":4013408103.64},{"date":"2026-08-21","current":112.812357,"twenty":-445.662886,"median":172.57995,"eighty":245.774025,"marketCap":3778875522.96},{"date":"2026-08-28","current":114.191675,"twenty":-444.681415,"median":171.69944,"eighty":244.665977,"marketCap":3825078550.57},{"date":"2026-09-04","current":120.218119,"twenty":-444.416873,"median":171.125205,"eighty":244.246526,"marketCap":4026946335.18},{"date":"2026-09-11","current":113.993217,"twenty":-443.358706,"median":170.839525,"eighty":243.230652,"marketCap":3818430784.57},{"date":"2026-09-18","current":128.771395,"twenty":-438.399131,"median":170.279278,"eighty":242.301839,"marketCap":4313455406.44},{"date":"2026-09-25","current":113.11909,"twenty":-435.525335,"median":170.22876,"eighty":242.197204,"marketCap":3789150143.08},{"date":"2026-10-02","current":106.450812,"twenty":-432.365699,"median":169.774316,"eighty":242.047247,"marketCap":3565782844.39},{"date":"2026-10-06","current":109.135498,"twenty":-430.395937,"median":169.706271,"eighty":241.476195,"marketCap":3655711771.28}],"updateTime":1791422550944},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TLX\",pageSize:20,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2673304624","title":"Telix Pharmaceuticals (ASX:TLX) Could Be 35% Below Fair Value On Pixclara Launch","url":"https://stock-news.laohu8.com/highlight/detail?id=2673304624","media":"Simply Wall St.","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673304624?lang=en_us&edition=fundamental","pubTime":"2026-10-08 06:27","pubTimestamp":1791412057,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals (ASX:TLX) has begun dosing the first patients in the U.S. with Pixclara, its FDA-approved PET imaging agent for glioma, marking the commercial roll out of this brain cancer diagnostic.\nThat Pixclara milestone comes after a busy few weeks for Telix Pharmaceuticals, including FDA Fast Track status for its BiPASS prostate cancer imaging program. The share price now trades at A$15.87 with a year to date share price return of 39.7% and a 5 year total shareholder return of...","market":"us","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-asxtlx-could-be-35-below-fair-value-on","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/telix-pharmaceuticals-asxtlx-could-be-35-below-fair-value-on","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK7067","TLX","BK4139","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673055551","title":"Telix Doses First US Patients With FDA-Approved Brain Cancer Imaging Drug","url":"https://stock-news.laohu8.com/highlight/detail?id=2673055551","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673055551?lang=en_us&edition=fundamental","pubTime":"2026-10-06 19:25","pubTimestamp":1791285937,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  said Tuesday it administered the first US doses of Pixclara, a Food and Drug Administration-approved positron emission tomography imaging drug for brain cancer imaging.The initial doses took place at medical centers in Cleveland and Indianapolis, starting the product's commercial availability in the country, the company said.PharmaLogic will be the manufacturing and pharmacy distribution partner to supply finished unit doses to the market, Telix said.The drug, also known as floretyrosine F-18, is used to help differentiate recurrent or progressive glioma from treatment-related changes in patients aged one month and above, it said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX.AU","BK7067","BK4585","BK4139","TLX","BK4588","LABU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673105523","title":"How Investors Are Reacting To Telix Pharmaceuticals (ASX:TLX) Fast Track Nod","url":"https://stock-news.laohu8.com/highlight/detail?id=2673105523","media":"Simply Wall St.","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673105523?lang=en_us&edition=fundamental","pubTime":"2026-10-06 18:22","pubTimestamp":1791282120,"startTime":"0","endTime":"0","summary":"In late September 2026, Telix Pharmaceuticals reported that the FDA granted Fast Track designation for its BiPASS program, which studies 68Ga-PSMA-PET imaging plus MRI to refine prostate cancer detection before biopsy, following completion of Phase 3 enrollment for Illuccix and Gozellix in this pre-biopsy setting.\nThe focus on using Illuccix and Gozellix earlier in the diagnostic pathway targets a large pool of men currently undergoing millions of biopsies where up to 75% return negative...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/6111000-choice1-card/1788937617532"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/how-investors-are-reacting-to-telix-pharmaceuticals-asxtlx-f","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/pharmaceuticals-biotech/asx-tlx/telix-pharmaceuticals-shares/news/how-investors-are-reacting-to-telix-pharmaceuticals-asxtlx-f","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["TLX.AU","TLX","ISBC","BK7067","BK4139","BK4211"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673999776","title":"Canaccord Genuity Keeps Their Buy Rating on Telix Pharmaceuticals (TLPPF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2673999776","media":"TIPRANKS","labels":["express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673999776?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:35","pubTimestamp":1791153321,"startTime":"0","endTime":"0","summary":"Canaccord Genuity analyst Shane Storey maintained a Buy rating on Telix Pharmaceuticals on October 2 and set a price target of A$31.50. The company...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-keeps-their-buy-rating-on-telix-pharmaceuticals-tlppf-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate","earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/canaccord-genuity-keeps-their-buy-rating-on-telix-pharmaceuticals-tlppf-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"express","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLPPF","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673637776","title":"Telix Pharmaceuticals Reports Lapse of Conditional Equity Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2673637776","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673637776?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:01","pubTimestamp":1791151295,"startTime":"0","endTime":"0","summary":"The latest update is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals Limited is a biopharmaceutical company listed on the ASX a...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-reports-lapse-of-conditional-equity-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-pharmaceuticals-reports-lapse-of-conditional-equity-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["REZ","EQR","BK4139","BK4585","BK4588","BK4215","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673686776","title":"Telix Issues 15,000 New Shares From Conversion of Unquoted Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2673686776","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673686776?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:01","pubTimestamp":1791151285,"startTime":"0","endTime":"0","summary":"An update from Telix Pharmaceuticals ( ($AU:TLX) ) is now available. Telix Pharmaceuticals has issued 15,000 new fully paid ordinary shares followi...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-issues-15000-new-shares-from-conversion-of-unquoted-securities?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-issues-15000-new-shares-from-conversion-of-unquoted-securities?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673577650","title":"Telix Adds 436,366 New Shares to ASX Listing","url":"https://stock-news.laohu8.com/highlight/detail?id=2673577650","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2673577650?lang=en_us&edition=fundamental","pubTime":"2026-10-05 06:01","pubTimestamp":1791151275,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals ( ($AU:TLX) ) has issued an update. Telix Pharmaceuticals has applied for quotation of 436,366 new ordinary fully paid shares...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-adds-436366-new-shares-to-asx-listing?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-adds-436366-new-shares-to-asx-listing?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672721541","title":"Liontown And 2 Other Australian Growth Stocks To Watch","url":"https://stock-news.laohu8.com/highlight/detail?id=2672721541","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672721541?lang=en_us&edition=fundamental","pubTime":"2026-10-04 04:22","pubTimestamp":1791058974,"startTime":"0","endTime":"0","summary":"Australian inflation recently hit 4%, and the Reserve Bank lifted the cash rate target to 4.60%. Higher borrowing costs can punish weak balance sheets, yet fast growing companies where insiders own a meaningful stake can sometimes handle tougher conditions more confidently. This piece looks at three such Australian growth stocks from our high insider ownership screen and explains what their latest numbers and management signals might mean for long term investors.\nThe three stocks discussed...","market":"hk","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2052000-choice2-card/1788935149464","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2052000-choice2-card/1788935149464"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-ltr/liontown-shares/news/liontown-and-2-other-australian-growth-stocks-to-watch","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-ltr/liontown-shares/news/liontown-and-2-other-australian-growth-stocks-to-watch","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GEAR.AU","USD.AU","BK7095","TLX","XAO.AU","VAP.AU","BEAR.AU","IMLC.AU","IOZ.AU","VAS.AU","QRE.AU","BK7137","DACE.AU","XKO.AU","ZYAU.AU","IIGF.AU","STW.AU","SLF.AU","USD","GYG.AU","EIGA.AU","E200.AU","LTR.AU","GIVE.AU","BBOZ.AU","QFN.AU","IISV.AU","OZF.AU","XJO.AU","BK7504","OZR.AU","BK4139","BK7067","TLX.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2672796025","title":"3 Australian Founder Led Growth Stocks To Own In October 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2672796025","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2672796025?lang=en_us&edition=fundamental","pubTime":"2026-10-02 07:23","pubTimestamp":1790896987,"startTime":"0","endTime":"0","summary":"Global bond yields have surged to multi decade highs, pushing borrowing costs up and putting pressure on richly priced Australian growth stocks. That kind of stress often reveals which businesses have conviction from the inside, where founders and executives keep meaningful stakes and stay focused on long term value. This article highlights three fast growing Australian stocks with significant insider ownership that align with that theme.\nThe three fast growing stocks covered below are just a...","market":"sg","thumbnail":"https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2053000-choice2-card/1788948823050","type":0,"news_type":0,"thumbnails":["https://simplywall.st/cdn-cgi/image/fit=cover,format=auto,width=320,height=180/https://images.simplywall.st/asset/industry/2053000-choice2-card/1788948823050"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/au/materials/asx-pdi/pdi-gold-shares/news/3-australian-founder-led-growth-stocks-to-own-in-october-202","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/au/materials/asx-pdi/pdi-gold-shares/news/3-australian-founder-led-growth-stocks-to-own-in-october-202","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["GEAR.AU","USD","BEAR.AU","DACE.AU","STW.AU","BBOZ.AU","GYG.AU","VAS.AU","IISV.AU","XKO.AU","QFN.AU","SLF.AU","OZF.AU","TLX","BK7067","BK7137","IMLC.AU","TLX.AU","USD.AU","IOZ.AU","E200.AU","GIVE.AU","VAP.AU","BK7104","QRE.AU","XAO.AU","XJO.AU","IIGF.AU","OZR.AU","BK4139","EIGA.AU","PDI.AU","ZYAU.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671228076","title":"Telix Wins FDA Fast Track for Pre-Biopsy Prostate Cancer Imaging Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2671228076","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671228076?lang=en_us&edition=fundamental","pubTime":"2026-09-30 07:15","pubTimestamp":1790723736,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has secured U.S. FDA Fast Track designation for its ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-fast-track-for-pre-biopsy-prostate-cancer-imaging-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-wins-fda-fast-track-for-pre-biopsy-prostate-cancer-imaging-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","BK4585","LABU","BK4139","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2671606264","title":"Ord Minnett Remains a Buy on Telix Pharmaceuticals (TLPPF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2671606264","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2671606264?lang=en_us&edition=fundamental","pubTime":"2026-09-29 09:35","pubTimestamp":1790645742,"startTime":"0","endTime":"0","summary":"Ord Minnett analyst maintained a Buy rating on Telix Pharmaceuticals today and set a price target of A$22.00. In addition to Ord Minnett, Telix Pha...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ord-minnett-remains-a-buy-on-telix-pharmaceuticals-tlppf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ord-minnett-remains-a-buy-on-telix-pharmaceuticals-tlppf-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","TLPPF","TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670100423","title":"Telix Pharmaceuticals Price Target Maintained with a $20.00/Share by HC Wainwright & Co.","url":"https://stock-news.laohu8.com/highlight/detail?id=2670100423","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670100423?lang=en_us&edition=fundamental","pubTime":"2026-09-25 22:40","pubTimestamp":1790347200,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLX/analyst-ratings","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670423017","title":"Analysts Offer Insights on NA Companies: Ford Motor (F) and Telix Pharmaceuticals Limited Unsponsored ADR (TLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2670423017","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670423017?lang=en_us&edition=fundamental","pubTime":"2026-09-25 22:30","pubTimestamp":1790346626,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on Ford Motor (F) and Telix Pharmaceuticals Limited Unsponsored...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-ford-motor-f-and-telix-pharmaceuticals-limited-unsponsored-adr-tlx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-na-companies-ford-motor-f-and-telix-pharmaceuticals-limited-unsponsored-adr-tlx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4555","BK4588","ARMH","APIE","F","DINT","TLX","BK4585","BK4141","DIVL","CVY","BK4574","NA","BK4516","AADR","FRDU","BK4139","FRDD","SAPH","BK4099"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2670626448","title":"Telix Director David Gill Boosts Nasdaq ADS Stake","url":"https://stock-news.laohu8.com/highlight/detail?id=2670626448","media":"TIPRANKS","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2670626448?lang=en_us&edition=fundamental","pubTime":"2026-09-25 13:47","pubTimestamp":1790315244,"startTime":"0","endTime":"0","summary":"The latest announcement is out from Telix Pharmaceuticals ( ($AU:TLX) ). Telix Pharmaceuticals has disclosed a change in director David Gill’s hold...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/telix-director-david-gill-boosts-nasdaq-ads-stake?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/telix-director-david-gill-boosts-nasdaq-ads-stake?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LCLG","TLX","NQmain","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669856064","title":"Telix Pharmaceuticals Price Target Maintained with a $22.00/Share by Wedbush","url":"https://stock-news.laohu8.com/highlight/detail?id=2669856064","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669856064?lang=en_us&edition=fundamental","pubTime":"2026-09-23 20:25","pubTimestamp":1790166300,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/TLX/analyst-ratings","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TLX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669951173","title":"Citi Remains a Buy on Telix Pharmaceuticals (TLPPF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669951173","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669951173?lang=en_us&edition=fundamental","pubTime":"2026-09-23 08:09","pubTimestamp":1790122149,"startTime":"0","endTime":"0","summary":"In a report released today, Laura Sutcliffe from Citi maintained a Buy rating on Telix Pharmaceuticals, with a price target of A$31.00. According t...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-telix-pharmaceuticals-tlppf-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/citi-remains-a-buy-on-telix-pharmaceuticals-tlppf-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","TLPPF","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669124129","title":"Analysts’ Top NA Picks: MillerKnoll (MLKN), Telix Pharmaceuticals Limited Unsponsored ADR (TLX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669124129","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669124129?lang=en_us&edition=fundamental","pubTime":"2026-09-23 03:20","pubTimestamp":1790104808,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the NA sector as 2 analysts just weighed in on MillerKnoll (MLKN) and Telix Pharmaceuticals Limited Unspons...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-top-na-picks-millerknoll-mlkn-telix-pharmaceuticals-limited-unsponsored-adr-tlx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-top-na-picks-millerknoll-mlkn-telix-pharmaceuticals-limited-unsponsored-adr-tlx-blurbs-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","NA","DINT","APIE","CVY","MLKN","AADR","ARMH","BK4139","DIVL","SAPH","BK4141","BK4143"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669110432","title":"RBC upgrades Telix to Outperform on ITM deal benefits","url":"https://stock-news.laohu8.com/highlight/detail?id=2669110432","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669110432?lang=en_us&edition=fundamental","pubTime":"2026-09-22 17:05","pubTimestamp":1790067921,"startTime":"0","endTime":"0","summary":"RBC Capital analyst Craig Wong-Pan upgraded Telix Pharmaceuticals (TLX) to Outperform from Sector Perform with a price target of A$21, up from A$19...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/rbc-upgrades-telix-to-outperform-on-itm-deal-benefits-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/rbc-upgrades-telix-to-outperform-on-itm-deal-benefits-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0128525929.USD","TLX","BK4207","LU0310800379.SGD","LU1267930573.SGD","LU0029864427.USD","GSIB","LU0708994859.HKD","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669192073","title":"UBS Sticks to Their Buy Rating for Telix Pharmaceuticals (TLPPF)","url":"https://stock-news.laohu8.com/highlight/detail?id=2669192073","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669192073?lang=en_us&edition=fundamental","pubTime":"2026-09-22 09:35","pubTimestamp":1790040916,"startTime":"0","endTime":"0","summary":"UBS analyst David Low maintained a Buy rating on Telix Pharmaceuticals today and set a price target of A$22.00. According to TipRanks, Low is a 4-s...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/ubs-sticks-to-their-buy-rating-for-telix-pharmaceuticals-tlppf-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/ubs-sticks-to-their-buy-rating-for-telix-pharmaceuticals-tlppf-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TLX","TLPPF"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2669196280","title":"Telix Pharmaceuticals Receives ASX Waivers on Share Issuance Timing for Acquisition Consideration","url":"https://stock-news.laohu8.com/highlight/detail?id=2669196280","media":"MT Newswires Live","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2669196280?lang=en_us&edition=fundamental","pubTime":"2026-09-22 07:25","pubTimestamp":1790033141,"startTime":"0","endTime":"0","summary":"Telix Pharmaceuticals  sought waivers of an ASX rule to allow shares issued as upfront consideration and future consideration to be issued more than three months after its extraordinary general meeting, as the timing is contingent on completion of closing conditions and achievement of specific milestones, according to a Tuesday Australian bourse filing.The company said ASX granted the waivers, with certain conditions, including that shares tied to the upfront payment are issued once the relevant deal conditions are met, and in any case no later than 12 months after shareholders approve the issue.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TLX.AU","BK7067","TLX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":1,"totalSize":199,"code":"91000000","status":"200"}]}}